Literature DB >> 23271762

Commentary on the State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer.

Ingrid J Hall1, Lisa C Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23271762      PMCID： PMC3540865          DOI： 10.1093/jncimonographs/lgs040

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN： 1052-6773


× No keyword cloud information.
  8 in total

Review 1.  Active surveillance for prostate cancer: progress and promise.

Authors:  Matthew R Cooperberg; Peter R Carroll; Laurence Klotz
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

2.  Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.

Authors:  Mark S Soloway; Cynthia T Soloway; Ahmed Eldefrawy; Kristell Acosta; Bruce Kava; Murugesan Manoharan
Journal:  Eur Urol       Date:  2010-08-20       Impact factor: 20.096

3.  National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Authors:  Patricia A Ganz; John M Barry; Wylie Burke; Nananda F Col; Phaedra S Corso; Everett Dodson; M Elizabeth Hammond; Barry A Kogan; Charles F Lynch; Lee Newcomer; Eric J Seifter; Janet A Tooze; Kasisomayajula Viswanath; Hunter Wessells
Journal:  Ann Intern Med       Date:  2012-02-20       Impact factor: 25.391

4.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

5.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Contemporary risk profile of prostate cancer in the United States.

Authors:  Yu-Hsuan Shao; Kitaw Demissie; Weichung Shih; Amit R Mehta; Mark N Stein; Calpurnyia B Roberts; Robert S Dipaola; Grace L Lu-Yao
Journal:  J Natl Cancer Inst       Date:  2009-08-27       Impact factor: 13.506

7.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Authors:  Laurence Klotz; Liying Zhang; Adam Lam; Robert Nam; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

8.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Authors:  H Gilbert Welch; Peter C Albertsen
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506
  8 in total
  4 in total

1.  'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.

Authors:  Robert J Volk; Stephanie L McFall; Scott B Cantor; Theresa L Byrd; Yen-Chi L Le; Deborah A Kuban; Patricia Dolan Mullen
Journal:  Psychooncology       Date:  2013-11-14       Impact factor: 3.894

2.  Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer.

Authors:  Yu Liu; Ingrid J Hall; Christopher Filson; David H Howard
Journal:  Urol Oncol       Date:  2020-12-09       Impact factor: 2.954

3.  Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study.

Authors:  Aaron T Seaman; Kathryn L Taylor; Kimberly Davis; Kenneth G Nepple; John H Lynch; Anthony D Oberle; Ingrid J Hall; Robert J Volk; Heather Schacht Reisinger; Richard M Hoffman
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

4.  Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.

Authors:  Shellie D Ellis; Soohyun Hwang; Emily Morrow; Kim S Kimminau; Kelly Goonan; Laurie Petty; Edward Ellerbeck; J Brantley Thrasher
Journal:  BMC Cancer       Date:  2021-05-31       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.